Walden 6630 Psychopharmacology
Midterm Study Guide With complete
solution 2024/25
Serotonin regulates - Mood, emotion, feeding, and reproductive behavior
II II II II II II II II II II
This class of antidepressants binds to presynaptic SERT and inhibits them from reuptake
II II II II II II II II II II II II II
of serotonin to increase levels in the synaptic cleft to bind with postsysnaptic 5HT2
II II II II II II II II II II II II II II
receptors - SSRIs
II II II II II
II First line therapy for MDD due to milder side effect profiles - SSRIs
II II II II II II II II II II II II II II
Six Common SSRIs - citalopram, escitalopram, fluoxetine, fluvoxamine, sertraline,
II II II II II II II II II II II
paroxetine
II
II Onset of therapeutic benefit from SSRIs - 4-6 weeks
II II II II II II II II II II
In addition to MDD, SSRIs also treat - Chronic Anxiety, PTSD, OCD, and eating
II II II II II II II II II II II II II II II II
disorders (bulimia)
II II
Five Common side effects of SSRIs include - Anxiety, insomnia, GI distress, sexual
II II II II II II II II II II II II II II II
dysfunction (ED), SIADH
II II II
Severe side effect of SSRIs in children/adolescents under age 25 years old - suicidal
II II II II II II II II II II II II II II II II
ideation
II
Life threatening adverse effect of SSRIs, especially when used in combination with other
II II II II II II II II II II II II II
serotonergic drugs (SNRIs, TCAs, MAOIs, etc.) - Serotonin Syndrome
II II II II II II II II II II II
Excess accumulation of serotonin resulting in overstimulation of the nervous system -
II II II II II II II II II II II II II II
Serotonin Syndrome
II II
Seven symptoms of Serotonin Syndrome - Flushing, hyperthermia, agitation, muscle
II II II II II II II II II II II II
rigidity, seizure, coma, HYPERreflexia
II II II II
II The treatment for serotonin syndrome - Cyproheptadine (5-HT2 receptor antagonist)
II II II II II II II II II II II
Cyproheptadine treats serotonin syndrome by - blocking 5-HT2 receptors (serotonin
II II II II II II II II II II II II
antagonist)
II
When SSRIs or SNRIs are stopped abruptly, common symptoms of withdrawal include -
II II II II II II II II II II II II II II II
Irritability, headaches, and insomnia
II II II II
, Medicine specific side effect of citalopram - Prolonged QT interval (normal=0.4.-0.44
II II II II II II II II II II II II II
seconds)
II
This SSRI is pregnancy category D due to associations with congenital heart defects -
II II II II II II II II II II II II II II II II
Paroxetine
II
II All SSRIs but paroxetine (D) are pregnancy category - C
II II II II II II II II II II II
Three SSRIs that are inhibitors of Cytochrome P450 enzymes - fluoxetine, fluvoxamine,
II II II II II II II II II II II II II II
and paroxetine
II II
Five common SNRIs include - duloxetine, venlafaxine, desvenlafaxine, milnacipran,
II II II II II II II II II II II
levomilnacipran
II
This antidepressant class of medications works by binding to presynaptic SERT and NET
II II II II II II II II II II II II II
to inhibit them from reuptake of serotonin and norepinephrine to increase their levels in
II II II II II II II II II II II II II II
the synaptic cleft - SNRIs
II II II II II II II
II In addition to MDD SNRIs treat - Anxiety and neuropathic pain (peripheral neuropathy)
II II II II II II II II II II II II II II
II Medication specific indications of duloxetine: - urinary incontinence and Fibromyalgia
II II II II II II II II II II II
Medication specific indications of venlafaxine: - social anxiety, panic disorders, PTSD,
II II II II II II II II II II II II II
OCD, postmenopausal hot flashes
II II II II
Six common side effects of SNRIs include: - Insomnia, nausea, sexual dysfunction,
II II II II II II II II II II II II II II
hypertension, sweating, headaches
II II II
Severe side effect of SNRIs in children/adolescents under age 25 years old: - suicidal
II II II II II II II II II II II II II II II II
ideation
II
Life threatening adverse effect of SNRIs, especially when used in combination with other
II II II II II II II II II II II II II
serotonergic drugs: - Serotonin Syndrome
II II II II II II II
II This SNRI is an inhibitor of Cytochrome P450 enzymes: - venlafaxine
II II II II II II II II II II II II
II This SNRI is hepatotoxic: - duloxetine
II II II II II II II
II MAOIs increase the levels of: - Serotonin, Norepinephrine, and Dopamine
II II II II II II II II II II II
II Norepinephrine regulates: - alertness and focus II II II II II II II
II Dopamine regulates: - cognitive function, motivation, and awakeness
II II II II II II II II II
In the synaptic cleft, Monoamine Oxidase A breaks down: - Serotonin, Norepinephrine,
II II II II II II II II II II II II II II
and Dopamine
II II